Region Ăstergötland Implements AI-Powered Stratipath Breast to Enhance Breast Cancer Diagnostics

Linköping University Hospital and Region Ăstergötland have chosen to implement Stratipath Breast as part of their clinical routine for early breast cancer diagnostics.
Region Uppsala chooses to implement AI-based risk profiling with Stratipath Breast

Region Uppsala, Swedenâs fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use.
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast

Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. The new capability strengthens clinical decision-making for neoadjuvant therapy.
Diagnexia and Stratipath Partner to Expand AI-Based Cancer Precision Diagnostics Across the UK and Europe

Diagnexia, and Stratipath AB are pleased to announce a strategic partnership. This collaboration will bring Stratipath Breast, an AI-based prognostic risk profiling tool for invasive breast cancer, to pathology laboratories, hospitals, and healthcare providers across the UK and Europe.
Professor Daniel Hayes Joins Stratipathâs Scientific Advisory Board

Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the companyâs Scientific Advisory Board. Professor Hayes will collaborate closely with the board, chaired by Professor Jonas Bergh, to further advance Stratipathâs innovative solutions in breast cancer precision diagnostics.
Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year

Stratipath has been recognized as one of the Gold Companies on NyTeknik – First with news about technology and IT. and AffĂ€rsvĂ€rldenâs prestigious 33-list â for the maximum three consecutive years!
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göranâs Hospital

Capio St Göranâs Hospital is one of the largest breast cancer clinics in Sweden treating more than 600 breast cancer patients annually. With this new collaboration, Unilabs will use Stratipath Breast on a selected group of these patients.
Article in âOncology in Swedenâ on the continuation of SwAIPP (Sweden AI Precision Pathology)

SwAIPP 2, the continuation of the SwAIPP project, has been funded by Swedenâs innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry.
Podcast: âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â

Johan Hartman is a guest at the Johnson & Johnson podcast âVi forskar för livetâ (âResearch for Lifeâ). The episode, titled âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â
Article at Genomeweb: âStratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Testâ

Johan Hartman is a guest at the Johnson & Johnson podcast âVi forskar för livetâ (âResearch for Lifeâ). The episode, titled âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â